AU2002223470A1 - Modulation of the transcription of pro-inflammatory gene products - Google Patents

Modulation of the transcription of pro-inflammatory gene products

Info

Publication number: AU2002223470A1
Authority: AU; Australia
Prior art keywords: transcription; pro; modulation; gene products; inflammatory gene
Prior art date: 2000-10-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002223470A

Other versions

AU2002223470B2 (en

Inventor

Markus Hecker

Andreas H. Wagner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Avontec GmbH

Original Assignee

Avontec GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-06

Filing date

2001-10-04

Publication date

2002-06-27

2000-10-06 Priority claimed from DE10049549A external-priority patent/DE10049549A1/en

2001-10-04 Application filed by Avontec GmbH filed Critical Avontec GmbH

2002-06-27 Publication of AU2002223470A1 publication Critical patent/AU2002223470A1/en

2007-01-04 Application granted granted Critical

2007-01-04 Publication of AU2002223470B2 publication Critical patent/AU2002223470B2/en

2021-10-04 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

230000000051 modifying Effects 0.000 title 1
230000000770 pro-inflamatory Effects 0.000 title 1
230000035897 transcription Effects 0.000 title 1

AU2002223470A 2000-10-06 2001-10-04 Modulation of the transcription of pro-inflammatory gene products Ceased AU2002223470B2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE10049549A DE10049549A1 (en)	2000-10-06	2000-10-06	Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40
DE10049549.4		2000-10-06
DE10059144A DE10059144A1 (en)	2000-10-06	2000-11-29	Modulation of the transcription of pro-inflammatory gene products
DE10059144.2		2000-11-29
PCT/DE2001/003835 WO2002029044A2 (en)	2000-10-06	2001-10-04	Modulation of the transcription of pro-inflammatory gene products

Publications (2)

Publication Number	Publication Date
AU2002223470A1 true AU2002223470A1 (en)	2002-06-27
AU2002223470B2 AU2002223470B2 (en)	2007-01-04

Family

ID=26007280

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2002223470A Ceased AU2002223470B2 (en)	2000-10-06	2001-10-04	Modulation of the transcription of pro-inflammatory gene products
AU2347002A Pending AU2347002A (en)	2000-10-06	2001-10-04	Modulation of the transcription of pro-inflammatory gene products

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2347002A Pending AU2347002A (en)	2000-10-06	2001-10-04	Modulation of the transcription of pro-inflammatory gene products

Country Status (11)

Country	Link
US (2)	US7524949B2 (en)
EP (1)	EP1325122A2 (en)
JP (1)	JP2004510787A (en)
CN (1)	CN100436578C (en)
AU (2)	AU2002223470B2 (en)
CA (1)	CA2424604A1 (en)
DE (2)	DE10049549A1 (en)
NO (1)	NO20031408D0 (en)
PL (1)	PL362987A1 (en)
RU (1)	RU2003107669A (en)
WO (1)	WO2002029044A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI308492B (en) *	2001-02-20	2009-04-11	Anges Mg Inc
DE10148828B4 (en) *	2001-10-04	2005-05-19	Avontec Gmbh	Modulation of the expression of STAT-1-dependent genes
US20040043950A1 (en) *	2002-01-03	2004-03-04	Board Of Regents, The University Of Texas System	WT1 antisense oligos for the inhibition of breast cancer
DE10240417A1 (en) *	2002-09-02	2004-03-11	Avontec Gmbh	Decoy oligonucleotide inhibition of CD40 expression
US20050215503A1 (en) *	2003-12-03	2005-09-29	Mcevoy Leslie M	HIF oligonucleotide decoy molecules
ES2542511T3 (en)	2007-05-11	2015-08-06	Adynxx, Inc.	Gene Expression and Pain
BRPI1010885A2 (en) *	2009-06-08	2015-09-22	Miragen Therapeutics	chemical modification motifs for mirna and mimetic inhibitors.
CA2872901A1 (en)	2012-05-10	2013-11-14	Adynxx, Inc.	Formulations for the delivery of active ingredients
WO2015095636A2 (en) *	2013-12-19	2015-06-25	The Children's Hospital Of Philadelphia	Interferon regulatory factor 1 (irf1) decoys and methods of use thereof
CN103751804B (en) *	2014-01-23	2015-09-30	武汉大学	The application of interferon regulatory factor 4 (IRF4) gene in coronary atherosclerotic heart disease
AU2015301491A1 (en)	2014-08-15	2017-02-02	Adynxx, Inc.	Oligonucleotide decoys for the treatment of pain
CN104258419A (en) *	2014-09-29	2015-01-07	武汉大学	Applications of interferon regulatory factor 1 gene in treatment of atherosclerosis
CN107580470B (en) *	2015-01-15	2021-06-22	皇家飞利浦有限公司	Instantaneous flow reserve-computed tomography
CN106620719A (en) *	2016-10-20	2017-05-10	武汉大学	IRF1 (interferon regulatory factor 1) as well as function and application of inhibitor of IRF1 in treatment of fatty liver and type-II diabetes
WO2020101880A1 (en) *	2018-11-14	2020-05-22	Oklahoma Medical Research Foundation	Compositions and methods of treating systemic lupus erythematosus
EP3894546A4 (en) *	2018-12-16	2022-12-21	Figene, LLC	Therapeutic uses of gene edited fibroblasts
CN114948965B (en) *	2022-07-18	2023-11-10	四川大学华西第二医院	Application of compound in preparation of medicine for preventing and treating tissue injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3847366B2 (en)	1996-02-22	2006-11-22	アンジェスＭｇ株式会社	Stationary mitotic cell growth agent using antisense oligonucleotide
US6060310A (en) *	1997-11-24	2000-05-09	The United States Of America As Represented By The Department Of Health And Human Services	Transcription factor decoy and tumor growth inhibitor
EP1100963A2 (en) *	1998-07-25	2001-05-23	AstraZeneca AB	Human ccr-2 gene polymorphisms
AU5337499A (en) *	1998-08-03	2000-03-06	East Carolina University	Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
WO2000044407A2 (en) *	1999-02-01	2000-08-03	Amgen Canada	Materials and methods to inhibit hodgkin and reed sternberg cell growth
CA2330022A1 (en) *	1999-04-06	2000-10-26	East Carolina University	Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
EP1165758A2 (en) *	1999-04-12	2002-01-02	Ribozyme Pharmaceuticals, Inc.	Regulation of the expression of transcriptional repressor genes using nucleic acid molecules

2000
- 2000-10-06 DE DE10049549A patent/DE10049549A1/en not_active Withdrawn
- 2000-11-29 DE DE10059144A patent/DE10059144A1/en not_active Withdrawn
2001
- 2001-10-04 WO PCT/DE2001/003835 patent/WO2002029044A2/en active Application Filing
- 2001-10-04 US US10/398,592 patent/US7524949B2/en not_active Expired - Fee Related
- 2001-10-04 JP JP2002532614A patent/JP2004510787A/en not_active Withdrawn
- 2001-10-04 PL PL01362987A patent/PL362987A1/en unknown
- 2001-10-04 EP EP01986318A patent/EP1325122A2/en not_active Withdrawn
- 2001-10-04 CA CA002424604A patent/CA2424604A1/en not_active Withdrawn
- 2001-10-04 AU AU2002223470A patent/AU2002223470B2/en not_active Ceased
- 2001-10-04 CN CNB018169465A patent/CN100436578C/en not_active Expired - Fee Related
- 2001-10-04 RU RU2003107669/13A patent/RU2003107669A/en not_active Application Discontinuation
- 2001-10-04 AU AU2347002A patent/AU2347002A/en active Pending
2003
- 2003-03-27 NO NO20031408A patent/NO20031408D0/en unknown
2009
- 2009-03-26 US US12/411,926 patent/US20090221686A1/en not_active Abandoned

Publication	Publication Date	Title
AU2002223470A1 (en)	2002-06-27	Modulation of the transcription of pro-inflammatory gene products
AU2347002A (en)	2002-04-15	Modulation of the transcription of pro-inflammatory gene products
AU2001259595A1 (en)	2001-11-20	Haplotypes of the crybb1 gene
AU2001290603A1 (en)	2002-03-13	Haplotypes of the or11a1 gene
AU2001253101A1 (en)	2001-10-30	Haplotypes of the scn2b gene
AU2001255330A1 (en)	2001-10-30	Haplotypes of the akr1b1 gene
AU2001255402A1 (en)	2001-10-30	Haplotypes of the npr1 gene
AU2001253431A1 (en)	2001-10-30	Haplotypes of the f9 gene
AU2001266759A1 (en)	2001-12-17	Haplotypes of the acp2 gene
AU2001286644A1 (en)	2002-03-13	Haplotypes of the gng7 gene
AU2001292815A1 (en)	2002-03-26	Haplotypes of the scya8 gene
AU2001273117A1 (en)	2002-01-14	Haplotypes of the appbp1 gene
AU2002227177A1 (en)	2002-04-29	Haplotypes of the scya21 gene
AU2001274995A1 (en)	2001-12-11	Haplotypes of the rlbp1 gene
AU2001249650A1 (en)	2001-10-15	Haplotypes of the chrnb3 gene
AU2002245073A1 (en)	2002-07-24	Haplotypes of the f2rli gene
AU2002213185A1 (en)	2002-04-29	Haplotypes of the chrm5 gene
AU2001255272A1 (en)	2001-10-30	Haplotypes of the calm1 gene
AU2001288423A1 (en)	2002-03-04	Haplotypes of the bmpr2 gene
AU2001296510A1 (en)	2002-04-08	Haplotypes of the admr gene
AU2002228727A1 (en)	2002-05-15	Haplotypes of the chrm4 gene
AU2002239511A1 (en)	2002-06-03	Haplotypes of the gsr gene
AU2001288422A1 (en)	2002-03-04	Haplotypes of the lipg gene
AU2001296381A1 (en)	2002-04-08	Haplotypes of the scyb6 gene
AU2001290557A1 (en)	2002-03-04	Haplotypes of the il1rl1lg gene